Magnetic Iron Oxide Nanoparticles

DBCAT005591Pharmacologic class

Synthesized nanoparticles related to iron oxide crystalline structures with magnetic properties useful for biomedical applications. Examples include hematite, magnetite and maghemite nanoparticles. A DrugBank category of 3 drugs. 3 of them are approved.

Drugs: Ferric oxide
Ferumoxides
Ferumoxsil

What you can answer from here — as of January 13, 2022

3DrugsEach linked to its full drug card

Listed above

1Drug targetEvery drug–target pair in the class, with bond type

104Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

Which targets do Magnetic Iron Oxide Nanoparticles share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account